Work

Downregulated miR-33b is a novel predictor associated with disease progression and poor prognosis in multiple myeloma

Year: 2015

Type: article

Study design: Observational Study

Source: Leukemia Research

DOI: 10.1016/j.leukres.2015.04.010

Authors: Fei Li, Mu Hao, Xiaoyan Feng, Meirong Zang, Yu Qin, Shuhua Yi, Zengjun Li, Yan Xu, Lili Zhou, Weiwei Sui, Shuhui Deng, Dehui Zou, Fenghuang Zhan, Lugui Qiu

Institutions: Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, First Affiliated Hospital of Nanchang University, State Key Laboratory of Experimental Hematology, University of Iowa

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Anita Borg Institute for Women and Technology, Academy of Medical Sciences, National Natural Science Foundation of China, Chinese Academy of Medical Sciences, Natural Science Foundation of Tianjin City, National Public Health Grand Research Foundation, Science and Technology Support Program of Jiangsu Province, National Cancer Institute

Awards: G1274971737, 1号染色体短臂不稳定-miRNA-320b低表达-上调VEGF参与多发性骨髓瘤发病的机制研究, G3902390150, G6241862448, G982035528

OpenAlex ID: W1973477322

FWCI: 1.885

Cites: 36

Cited by: 26

Related to: 10